Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ximnitican Injection Monotherapy in Advanced Colorectal Cancer
CTR20181662Phase 2Terminated
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ximingtecan in colorectal cancer (CRC), sponsored by Shanghai Institute of Materia Medica. Started Sep 2018; status: terminated.
02
Drugs
ximingtecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20181662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181662.